Vaccine value profile for norovirus.

"Declaration of Competing Interest BAL reports personal fees from Epidemiological Research and Methods, LLC. MO acknowledges financial support from ANID PIA/ PUENTE AFB220003 and reports receiving grants and research support from Janssen Vaccines & Prevention B.V., Bharat Biotech International Limited, and HilleVax Inc. CFL declares that he receives research grant funding to his Institute from Takeda Vaccines Inc. and HilleVax Inc. for norovirus epidemiology and a norovirus vaccine phase II trial, respectively. All other authors declare no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. This supplement was sponsored by the World Health Organization’s Immunization, Vaccines, and Biologicals unit. The authors alone are responsible for the views expressed in each article and they do not necessarily represent the views, decisions, or policies of the institutions with which they are affiliated."

"The team would like to sincerely thank the Office of Medical Research staff Meghana Veeramachaneni and Amber Emerson for their invaluable editing and project management assistance. This work in part was also supported by the Bill & Melinda Gates Foundation Seattle, WA [INV029307]."